Skip to content

Sotera Health (SHC) — insider trading

Health Care · NASDAQ

Sotera Health (SHC) has 21 reported SEC Form 4 insider transactions in our data, including 6 open-market sales among the most recent 21 (latest 2026-08-17).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-08-17 Petras Michael B. Jr. Director, Officer (Executive Chairman) Open-market sale 850,000 $18.50 $15.73M Form 4
2026-08-17 Petras Michael B. Jr. Director, Officer (Executive Chairman) Open-market sale 294,515 $18.50 $5.45M Form 4
2026-08-07 Rutz Michael P Officer (President of Sterigenics) Open-market sale 150,000 $18.84 $2.83M Form 4
2026-08-05 Lyons Jonathan M. Officer (Sr. Vice President, CFO) Shares withheld for taxes / exercise cost 11,316 $17.98 $203.5K Form 4
2026-05-26 SHADER ALTON Director, Officer (Chief Executive Officer) Grant / award / vesting (derivative) 101,817 — $0 Form 4
2026-05-26 SHADER ALTON Director, Officer (Chief Executive Officer) Grant / award / vesting 203,634 — $0 Form 4
2026-05-26 SHADER ALTON Director, Officer (Chief Executive Officer) Grant / award / vesting 375,939 — $0 Form 4
2026-05-22 Wheadon David E. Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Simon, Christopher Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Chen Ruoxi Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 PETRELLA VINCENT K Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Neary James Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Flynn Karen Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 CUNNINGHAM SEAN LAURENCE Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Krause Kenneth D. Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Kyle Richard G Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-22 Klee Ann R. Director Grant / award / vesting 14,970 — $0 Form 4
2026-05-13 GTCR INVESTMENT XI LLC; GTCR FUND XI/A LP; GTCR FUND XI/C LP; GTCR CO-INVEST XI LP; GTCR PARTNERS XI/A&C LP Director, 10% owner Open-market sale 12,735,301 $15.17 $193.17M Form 4
2026-05-13 WARBURG PINCUS & CO.; Bull Co-Invest L.P.; Warburg Pincus Private Equity XI, L.P.; Bull Holdco L.P.; Warburg Pincus Partners II, L.P.; Warburg Pincus Private Equity XI-B, L.P.; Warburg Pincus XI Partners, L.P.; Warburg Pincus XI, L.P.; WP Global LLC; WP XI Partners, L.P. Director, 10% owner Open-market sale 19,102,952 $15.17 $289.75M Form 4
2026-05-13 WARBURG PINCUS & CO.; Warburg Pincus (Bermuda) Private Equity GP Ltd.; Warburg Pincus (Cayman) XI, L.P.; WARBURG PINCUS LLC; Warburg Pincus Partners GP LLC; Warburg Pincus Partners II (Cayman), L.P.; Warburg Pincus Private Equity XI-C, L.P.; Warburg Pincus XI-C, LLC Director, 10% owner Open-market sale 19,102,952 $15.17 $289.75M Form 4
2026-03-31 DIMITRIEF ALEXANDER Officer (Former SVP, GC and Sec.) Shares withheld for taxes / exercise cost 7,941 $14.34 $113.9K Form 4

Ask the chat about SHC's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Sotera Health (SHC).

Last updated 2026-08-17 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.